Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$84.3 - $94.31 $3,203 - $3,583
-38 Reduced 1.0%
3,775 $348,000
Q1 2024

Apr 15, 2024

BUY
$72.54 - $95.56 $89,949 - $118,494
1,240 Added 48.19%
3,813 $364,000
Q4 2023

Jan 12, 2024

SELL
$61.71 - $77.76 $65,350 - $82,347
-1,059 Reduced 29.16%
2,573 $196,000
Q3 2023

Oct 17, 2023

SELL
$69.28 - $93.38 $61,312 - $82,641
-885 Reduced 19.59%
3,632 $251,000
Q2 2023

Jul 26, 2023

BUY
$81.41 - $94.33 $10,664 - $12,357
131 Added 2.99%
4,517 $426,000
Q1 2023

May 04, 2023

BUY
$74.26 - $84.51 $32,228 - $36,677
434 Added 10.98%
4,386 $362,000
Q4 2022

Feb 03, 2023

BUY
$68.3 - $87.44 $269,921 - $345,562
3,952 New
3,952 $294,000
Q2 2022

Aug 02, 2022

BUY
$86.5 - $128.27 $104,838 - $155,463
1,212 New
1,212 $115,000
Q4 2021

Jan 18, 2022

SELL
$106.37 - $130.68 $132,217 - $162,435
-1,243 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$102.91 - $122.75 $9,158 - $10,924
89 Added 7.71%
1,243 $141,000
Q2 2021

Aug 04, 2021

BUY
$83.84 - $104.76 $34,290 - $42,846
409 Added 54.9%
1,154 $120,000
Q1 2021

Apr 15, 2021

SELL
$78.68 - $90.67 $4,484 - $5,168
-57 Reduced 7.11%
745 $62,000
Q4 2020

Jan 12, 2021

BUY
$71.69 - $91.23 $19,284 - $24,540
269 Added 50.47%
802 $73,000
Q3 2020

Oct 13, 2020

BUY
$67.19 - $87.44 $14,177 - $18,449
211 Added 65.53%
533 $43,000
Q2 2020

Aug 06, 2020

BUY
$57.54 - $76.95 $13,924 - $18,621
242 Added 302.5%
322 $22,000
Q1 2020

Apr 29, 2020

BUY
$52.41 - $81.0 $1,572 - $2,430
30 Added 60.0%
80 $15,000
Q3 2019

Oct 10, 2019

BUY
$61.55 - $75.43 $246 - $301
4 Added 8.7%
50 $11,000
Q1 2019

Apr 03, 2019

BUY
$47.89 - $64.05 $1,771 - $2,369
37 Added 411.11%
46 $9,000
Q4 2018

Jan 14, 2019

BUY
$46.41 - $56.94 $417 - $512
9 New
9 $1,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.